Healthcare technology startup BioStack has raised $9.5 million in a seed funding round backed by Peak XV, Afore Capital, DCVC, Emerson Collective, SV Angel, Verdict Capital, Streamlined Ventures and Y Combinator.
The proceeds will be directed towards expanding its international operations, advancing technology development and strengthening its engineering and research teams.
The startup is developing a healthcare data infrastructure network across the US, India, Brazil and Argentina, with access to over 100 million de-identified patient records.
Founded by Sanat Mishra, BioStack works to consolidate fragmented clinical data from hospitals and healthcare systems into comprehensive, longitudinal patient records. These records bring together clinical notes, laboratory reports, medical imaging, medication details, treatment histories and patient outcomes.
BioStack develops proprietary datasets using de-identified clinical information to facilitate medical research, drug development and the training and evaluation of healthcare AI models. Its platform supports several applications, including disease modelling, biomarker discovery, patient stratification and the analysis of treatment responses.
The company claims to have brought together several hundred thousand X-ray, MRI and CT scans, alongside millions of telehealth audio transcripts and other clinical records. In India, BioStack is also facilitating connections between cancer patients and an investigational cancer vaccine programme.
Additionally, its platform features customised workflows designed around the requirements of individual healthcare providers and their respective data privacy protocols.
